1211 Rayze Raise
BioCentury & Getty Images


RayzeBio gets unexpected lift from broad investor appetite for targeted radiotherapies

With a $105 million series B, the radiopharmaceuticals platform newco can pursue multiple programs in parallel

Dec 12, 2020 | 1:48 AM GMT

Encountering unanticipated investor interest after closing its series A round,  RayzeBio followed

Read the full 504 word article

How to gain access

Continue reading with a
two-week free trial.